Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Florida
Essen Biotech
Essen Biotech
Cancer Research UK
Incyte Corporation
University of Colorado, Denver
Washington University School of Medicine
University of Michigan Rogel Cancer Center
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Vector Vitale LLC
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Duke University
Blue Note Therapeutics
Celgene
Celgene
University of Wisconsin, Madison
AbbVie
Aprea Therapeutics
Alliance for Clinical Trials in Oncology
Michigan State University
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Tesaro, Inc.
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Stanford University
National Institutes of Health Clinical Center (CC)
Novacea